CY1105463T1 - Ελεγχομενη χορηγηση αντικαταθλιπτικων - Google Patents
Ελεγχομενη χορηγηση αντικαταθλιπτικωνInfo
- Publication number
- CY1105463T1 CY1105463T1 CY20061100941T CY061100941T CY1105463T1 CY 1105463 T1 CY1105463 T1 CY 1105463T1 CY 20061100941 T CY20061100941 T CY 20061100941T CY 061100941 T CY061100941 T CY 061100941T CY 1105463 T1 CY1105463 T1 CY 1105463T1
- Authority
- CY
- Cyprus
- Prior art keywords
- adphilistics
- controlled administration
- controlled
- administration
- triazolones
- Prior art date
Links
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- -1 phenoxyethyl-substituted 1,2,4-triazolones Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Περιγράφονται μορφές δόσεως και μέθοδοι για την ελεγχόμενη απελευθέρωση αντικαταθλιπτικών, όττως αυτά που δίνονται ως παράδειγμα με τις φαινοξυαιθυλ-υποκατεστημένες 1,2,4-τριαζολόνες, επί μία παρατεταμένη χρονική περίοδο.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10675898P | 1998-11-02 | 1998-11-02 | |
US10667798P | 1998-11-02 | 1998-11-02 | |
PCT/US1999/025017 WO2000025790A1 (en) | 1998-11-02 | 1999-10-26 | Controlled delivery of antidepressants |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1105463T1 true CY1105463T1 (el) | 2010-04-28 |
Family
ID=26803899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061100941T CY1105463T1 (el) | 1998-11-02 | 2006-07-07 | Ελεγχομενη χορηγηση αντικαταθλιπτικων |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1126853B1 (el) |
JP (1) | JP4711510B2 (el) |
KR (2) | KR20070040421A (el) |
AT (1) | ATE323493T1 (el) |
AU (1) | AU1230800A (el) |
CA (1) | CA2349719C (el) |
CY (1) | CY1105463T1 (el) |
DE (1) | DE69930952T2 (el) |
DK (1) | DK1126853T3 (el) |
ES (1) | ES2260962T3 (el) |
HK (1) | HK1038515A1 (el) |
PT (1) | PT1126853E (el) |
WO (1) | WO2000025790A1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050232995A1 (en) * | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
MXPA05001184A (es) * | 2002-07-29 | 2005-09-12 | Johnson & Johnson | Formulaciones y formas de dosificacion para administracion controlada de topiramato. |
WO2004010981A1 (en) * | 2002-07-29 | 2004-02-05 | Alza Corporation | Methods and dosage forms for controlled delivery of paliperidone |
AU2004275835B2 (en) * | 2003-09-26 | 2011-06-23 | Alza Corporation | Controlled release formulations exhibiting an ascending rate of release |
NZ546148A (en) | 2003-09-26 | 2009-05-31 | Alza Corp | Drug coating providing high drug loading and methods for providing the same |
CN101703488B (zh) * | 2008-12-16 | 2013-02-20 | 北京科信必成医药科技发展有限公司 | 具有润滑层结构的双层渗透泵控释片及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5082668A (en) * | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
US5116852A (en) * | 1990-12-03 | 1992-05-26 | Bristol-Myers Squibb Co. | Treatment of sleep disorders |
US5330762A (en) * | 1992-02-27 | 1994-07-19 | Alza Corporation | Tandospiaine antidepressive therapy |
ES2124910T3 (es) * | 1993-08-31 | 1999-02-16 | Alza Corp | Dispensador que contiene un agente hidrofobo. |
US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
CA2160423A1 (en) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
DE69725345T2 (de) * | 1996-02-15 | 2004-08-19 | Janssen Pharmaceutica N.V. | Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden |
AU3290397A (en) * | 1996-06-10 | 1998-01-07 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
US6143325A (en) * | 1998-06-05 | 2000-11-07 | Bristol-Myers Squibb Company | Nefazodone dosage form |
-
1999
- 1999-10-26 CA CA002349719A patent/CA2349719C/en not_active Expired - Lifetime
- 1999-10-26 WO PCT/US1999/025017 patent/WO2000025790A1/en not_active Application Discontinuation
- 1999-10-26 KR KR1020077006959A patent/KR20070040421A/ko not_active Application Discontinuation
- 1999-10-26 DK DK99971322T patent/DK1126853T3/da active
- 1999-10-26 PT PT99971322T patent/PT1126853E/pt unknown
- 1999-10-26 KR KR1020017005537A patent/KR100734193B1/ko active IP Right Grant
- 1999-10-26 ES ES99971322T patent/ES2260962T3/es not_active Expired - Lifetime
- 1999-10-26 EP EP99971322A patent/EP1126853B1/en not_active Expired - Lifetime
- 1999-10-26 AU AU12308/00A patent/AU1230800A/en not_active Abandoned
- 1999-10-26 JP JP2000579231A patent/JP4711510B2/ja not_active Expired - Lifetime
- 1999-10-26 DE DE69930952T patent/DE69930952T2/de not_active Expired - Lifetime
- 1999-10-26 AT AT99971322T patent/ATE323493T1/de active
-
2002
- 2002-01-15 HK HK02100276A patent/HK1038515A1/xx not_active IP Right Cessation
-
2006
- 2006-07-07 CY CY20061100941T patent/CY1105463T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2349719A1 (en) | 2000-05-11 |
DE69930952D1 (de) | 2006-05-24 |
WO2000025790A1 (en) | 2000-05-11 |
EP1126853B1 (en) | 2006-04-19 |
EP1126853A1 (en) | 2001-08-29 |
ATE323493T1 (de) | 2006-05-15 |
KR100734193B1 (ko) | 2007-07-02 |
AU1230800A (en) | 2000-05-22 |
KR20070040421A (ko) | 2007-04-16 |
JP2002528505A (ja) | 2002-09-03 |
HK1038515A1 (en) | 2002-03-22 |
ES2260962T3 (es) | 2006-11-01 |
JP4711510B2 (ja) | 2011-06-29 |
DE69930952T2 (de) | 2006-08-31 |
KR20010075677A (ko) | 2001-08-09 |
DK1126853T3 (da) | 2006-08-14 |
PT1126853E (pt) | 2006-07-31 |
CA2349719C (en) | 2009-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2184149T3 (es) | Paclitaxeles 6-tio sustituidos. | |
BR0107942A (pt) | Polìmeros de proteìna de liberação lenta | |
ES2114487B1 (es) | Mezcla estabilizante sinergistica. | |
TR200100922T2 (tr) | Aktif maddelerin akciğerler yolu ile tatbik edilmesi. | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
TR200100366T2 (tr) | Aktif madde dağıtmaya mahsus bileşikler ve bileşimler. | |
TR199900639T2 (xx) | Olanzapin dihidrat D. | |
BR9713147A (pt) | Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal. | |
TR199800077T1 (xx) | Kontroll� ��z�len paroksetin terkipleri. | |
DK0994710T3 (da) | Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin | |
CY1105463T1 (el) | Ελεγχομενη χορηγηση αντικαταθλιπτικων | |
HUP9903931A2 (hu) | Indolopirrolokarbazolok citotoxikus aminocukor- és más rokon jellegű cukorszármazékai | |
DK0934065T3 (da) | Hidtil ukendte cruptophycinderivater som antieoplastiske midler | |
AR016981A2 (es) | Polipeptidos sinteticos | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
ES2181168T3 (es) | Mezclas solidas a base de sulfonilureas y adyuvantes. | |
ES2167678T3 (es) | Tratamiento y profilaxis de la pancreatitis. | |
BR9608255A (pt) | Sistema terapéutico transdérmico (stt) para a administração de testosterona | |
GT199900062A (es) | Preparados efervescentes. | |
ATE233745T1 (de) | Arzneistoffe | |
DE69206913D1 (de) | Formulierungen zur Behandlung der vaginalen Trockenheit | |
AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
UY24915A1 (es) | Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen | |
UA32598C2 (uk) | Спосіб одержання лікарської форми карбамазепіну | |
ES2195405T3 (es) | Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion. |